Skip to content
Parakho

Q1 FY27, unaudited

Revenue
₹2,205.39 Cr
Profit after tax
₹183.60 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations2,205.39+9.91%
Other income63.71+430.47%
Total income2,269.10+12.41%
Employee benefit expense105.33+3.80%
Finance costs17.67−11.96%
Depreciation & amortisation31.43−2.27%
Total expenses2,026.88+12.61%
Profit before tax242.22+10.77%
Tax expense58.62+17.76%
Profit after tax183.60+8.71%
Total comprehensive income184.21+8.03%
Earnings per share
Earnings per share, basic₹9.55
Earnings per share, diluted₹9.54

Q1 FY27 unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base unaudited, from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Godrej Agrovet reported consolidated Q4 FY'26 revenue of Rs 2,333 crore, up 9% year-on-year, with profit before tax excluding exceptional items up 16.8% to Rs 87 crore. For the full year, consolidated revenue crossed Rs 10,000 crore for the first time at Rs 10,233 crore, up 9%, while PBT excluding exceptional items rose 17.2% to Rs 569 crore. Management described growth across Animal Nutrition, oil palm and Astec LifeSciences, while Crop Care remained impacted by carry-forward channel inventory and Creamline Dairy profitability stayed under pressure from elevated milk procurement costs.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 66 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 25 Aug 2026.